| Literature DB >> 30159052 |
Rania M Abdel Halim1, Nevine N Kassem1, Basma S Mahmoud1.
Abstract
AIMS: To evaluate three in vitro phenotypic methods; tissue culture plate, tube method, and Congo red agar for detection of biofilm formation in staphylococci and assess the relation of biofilm formation with methicillin resistance and anti-microbial resistance.Entities:
Keywords: Biofilm; CRA; Methicillin; Staphylococci; TCP; TM
Year: 2018 PMID: 30159052 PMCID: PMC6108796 DOI: 10.3889/oamjms.2018.246
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Figure 1Tissue culture plate showing different biofilm intensities; C3: Non-biofilm producer; C8: moderate biofilm producer; F4: strong biofilm producer
Interpretation of results of Tissue Culture Plate method
| OD Value | Biofilm Formation |
|---|---|
| <0.120 | Non-biofilm producer |
| 0.120-0.240 | Moderate biofilm producer |
| >0.240 | Strong biofilm producer |
Figure 2Tube method with different degrees of biofilm formation
Figure 3A) CRA showing black colonies with dry crystalline consistency (positive for biofilm formation); B) CRA showing red colonies with darkening at the centre (negative for biofilm formation)
Figure 4Comparison between TCP, TM and CRA as regards detection of biofilm formation in Staphylococci
Comparison between TM and TCP as regards biofilm production
| TCP | |||||||
|---|---|---|---|---|---|---|---|
| Non- producers | Moderate producers | Strong producers | Total Staph. isolates | P value | Chi- square | ||
| TM | Non- producers | 32 | 29 | 25 | 86 | <0.001 | 20.445 |
| 82.1% | 63.0% | 38.5% | 57.3% | ||||
| Moderate producers | 6 | 13 | 34 | 53 | |||
| 15.4% | 28.3% | 52.3% | 35.3% | ||||
| Strong producers | 1 | 4 | 6 | 11 | |||
| 2.6% | 8.7% | 9.2% | 7.3% | ||||
| Total Staph. isolates | 39 | 46 | 65 | 150 | |||
Detection of biofilm formation in staphylococci in relation to methicillin susceptibility
| S. aureus (no 78) | CoNS (no 72) | ||||||
|---|---|---|---|---|---|---|---|
| MRSA 68 | MSSA 10 | MRCoNS 63 | MSCoNS 9 | MRS 131 | MSS 19 | Total staphylococci 150 | |
| Tissue culture plate method (strong) | 3 | 6 | 24 | 5 | 54 | 11 | 65 |
| 0 | |||||||
| % | 46.2% | 9.2% | 36.9% | 7.7% | 36% | 7.3% | 43.3% |
| Tissue culture plate method (moderate) | 2 | 2 | 21 | 2 | 42 | 4 | 46 |
| 1 | |||||||
| % | 45.7% | 4.3% | 45.7% | 4.3% | 28% | 2.6% | 30.7% |
| Tissue culture plate method (negative) | 1 | 2 | 18 | 2 | 35 | 4 | 39 |
| 7 | |||||||
| % | 43.6% | 5.1% | 46.2% | 5.1% | 23.3% | 2.6% | 26% |
| Total positive | 5 1 | 8 | 45 | 7 | 96 | 15 | 111 |
| % | 45.9% | 7.2% | 40.5% | 6.3% | 64% | 10% | 74% |
| Tube method (strong) | 6 | 0 | 5 | 0 | 11 | 0 | 11 |
| % | 54.5% | 0% | 45.5% | 0% | 7.3% | 0% | 7.3% |
| Tube method (moderate) | 21 | 7 | 22 | 3 | 43 | 10 | 53 |
| % | 39.6% | 13.2% | 41.5% | 5.7% | 28.6% | 6.7% | 35.3% |
| Tube method (negative) | 41 | 3 | 36 | 6 | 77 | 9 | 86 |
| Total positive | 27 | 7 | 27 | 3 | 54 | 10 | 64 |
| % | 42.2% | 10.9% | 42.2% | 4.7% | 36.6% | 6.7% | 42.7% |
MRSA: Methicillin-Resistant Staphylococcus aureus; MSSA: Methicillin-Sensitive Staphylococcus aureus; MRCONS: Methicillin-Resistant Coagulase negative Staphylococci; MSCONS: Methicillin Sensitive Coagulase negative Staphylococci; MRS: Methicillin-Resistant Staphylococci; MSS: Methicillin Sensitive Staphylococci.
Biofilm production in CONS species
| CONS species | |||||
|---|---|---|---|---|---|
| Biofilm producers by TCP (111) | 30 | 11 | 10 | 0 | 1 |
| % from total biofilm producers | 57.7% | 21.2% | 19.2% | 0% | 1.9% |
| Biofilm producers by TM (64) | 14 | 10 | 6 | 0 | 0 |
| % from total biofilm producers | 46.7% | 33.3% | 20% | 0% | 0% |
Figure 5Biofilm production in staphylococci isolated from various clinical specimens (TCP method)
Figure 6Antibiotic resistance pattern of Biofilm producers and non-producers staphylococci; Fox: Cefoxitin; LZD: Linezolid; levo: Levofloxacin; CN: Gentamycin; Da: Clindamycin; E: Erythromycin; Do: Doxycycline; VA: Vancomycin